Reviva Pharmaceuticals Holdings - Warrants (25/12/2025) Current Cash

Reviva Pharmaceuticals Holdings - Warrants (25/12/2025) (RVPHW) currently reports a current cash of $22M as of March 2026. That compares with $5.3M in the prior-year period — up 319.5% year over year. Use the charts on this page to explore Reviva Pharmaceuticals Holdings - Warrants (25/12/2025)'s current cash history and peer comparisons.

Reviva Pharmaceuticals Holdings - Warrants (25/12/2025)'s current cash increased from $5.3M to $22M — a 319.5% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Reviva Pharmaceuticals Holdings - Warrants (25/12/2025) reported $22M in current cash as of March 2026. That compares with $5.3M in the prior-year period — up 319.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $22M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Reviva Pharmaceuticals Holdings - Warrants (25/12/2025), and consider following RVPHW for alerts when major investors trade the stock.

Reviva Pharmaceuticals Holdings - Warrants (25/12/2025) is classified in the Healthcare sector. On current cash, it currently shows $22M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing RVPHW with unrelated industries.